Wenjie Li

21PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersNutritional epidemiologyMolecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Feb 04, 2026
Prognostic Significance of Lymph Node Ratio for Overall Survival in Patients with Lymph Node-Positive Bladder Cancer Post-Radical Cystectomy and Chemotherapy: A Multicenter Cohort Analysis.

Yanjun Wang, Songbin Guo, Jiamin Zeng

|Jan 06, 2026
Lipid metabolism-inflammation crosstalk and risk of incident cancer, cardiovascular diseases, and stroke among individuals with prediabetes: findings from a nationwide, population based, prospective cohort study.

Wenjie Li, Jian Chen, Yiming Fu

|Apr 15, 2025
Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis.

Wenjie Li, Wei Wang

|Feb 06, 2025
Real-world pharmacovigilance analysis unveils the toxicity profile of amivantamab targeting EGFR exon 20 insertion mutations in non-small cell lung cancer.

Jing Zhang, Wenjie Li

|Nov 21, 2024
KRAS-G12 inhibitors in lung cancer therapy: unveiling the toxicity profile through a pharmacovigilance study.

Wenjie Li, Wei Wang

|Sep 12, 2024
Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system.

Wenjie Li, Ruxue Lv, Wei Wang

Pageof 4

Frequent Collaborators

12 joint publications

Wei Wang

2 joint publications

Peixin Dong

1 joint publications

Yanbin Zhou

1 joint publications

Ruxue Lv